Current Report — Form 8-K Filing Table of Contents
Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 31K
2: EX-99.1 Miscellaneous Exhibit HTML 53K
9: R1 Document and Entity Information HTML 48K
11: XML IDEA XML File -- Filing Summary XML 12K
8: XML XBRL Instance -- sbra-20210308_htm XML 22K
10: EXCEL IDEA Workbook of Financial Reports XLSX 6K
4: EX-101.CAL XBRL Calculations -- sbra-20210308_cal XML 7K
5: EX-101.DEF XBRL Definitions -- sbra-20210308_def XML 9K
6: EX-101.LAB XBRL Labels -- sbra-20210308_lab XML 70K
7: EX-101.PRE XBRL Presentations -- sbra-20210308_pre XML 35K
3: EX-101.SCH XBRL Schema -- sbra-20210308 XSD 11K
12: JSON XBRL Instance as JSON Data -- MetaLinks 12± 18K
13: ZIP XBRL Zipped Folder -- 0001492298-21-000018-xbrl Zip 28K
Registrant's telephone number including area code: (i888) i393-8248
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
iCommon stock, $0.01 par value
iSBRA
iThe
Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
i☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Item 7.01
Regulation
FD Disclosure.
On March 8-11, 2021, Sabra Health Care REIT, Inc. (“Sabra”) intends to present the materials attached to this report as Exhibit 99.1 in investor presentations. The furnishing of these materials is not intended to constitute a representation that such furnishing is required by Regulation FD or other securities laws, or that the presentation materials include material investor information that is not otherwise publicly available. In addition, Sabra does not assume any obligation to update such information in the future.
Cover
Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
